Literature DB >> 2432000

Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodies.

M R Walker, A Solomon, N R Ling, B Brown, J A Lowe, D Hardie, R Jefferis.   

Abstract

Following immunization with various lambda Bence-Jones proteins, over 100 hybridomas were established. A majority of the monoclonal antibodies (McAb) produced were demonstrated to recognize epitopes common to all lambda chains or unique to the immunogen. Twenty-nine McAb exhibited profiles of 'restricted' reactivity. Analysis with a panel of serologically defined antigens allowed McAb recognizing the lambda II subgroup to be identified. Other McAb recognized epitopes selectively expressed by lambda II and lambda III subgroup proteins. A further twenty-one McAb exhibited individual specificity profiles, some of which detect minor lambda chain subpopulations. Several of these McAb have potential for analysis of the clonality of specific antibody responses and for detecting monoclonal B-cell proliferations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432000      PMCID: PMC1453201     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Differences in the enzymatic digestibility of the variable and constant halves of Bence-Jones protein with temperature.

Authors:  B K Seon; O A Roholt; D Pressman
Journal:  J Biol Chem       Date:  1972-04-10       Impact factor: 5.157

3.  Recovery of the native conformations of the variable and constant halves of an immunoglobulin light chain upon renaturation from the linear random coil state.

Authors:  F A Karlsson; I Björk; I Berggård
Journal:  Immunochemistry       Date:  1972-11

4.  Light chains of human immunoglobulins.

Authors:  A Solomon
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

6.  The development of difference turbidimetric analysis for monoclonal antibodies to human IgG.

Authors:  J Steensgaard; C Jacobsen; J Lowe; D Hardie; N R Ling; R Jefferis
Journal:  Mol Immunol       Date:  1980-10       Impact factor: 4.407

7.  Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes.

Authors:  C B Reimer; D J Phillips; C H Aloisio; D D Moore; G G Galland; T W Wells; C M Black; J S McDougal
Journal:  Hybridoma       Date:  1984

8.  Detection of free kappa chains in human serum and urine using pairs of monoclonal antibodies reacting with C kappa epitopes not available on whole immunoglobulins.

Authors:  N R Ling; J Lowe; D Hardie; S Evans; R Jefferis
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  The VKIIIb light chain sub-subgroup: restricted association with mu heavy chain in normal human serum.

Authors:  J A Moynihan; R J Looney; G N Abraham
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

10.  Variable-region sequences of five human lambda-chain proteins reacting with an idiotypic antibody to the MCG Bence-Jones protein.

Authors:  D Zhu; H S Kim; H F Deutsch
Journal:  Mol Immunol       Date:  1983-10       Impact factor: 4.407

View more
  2 in total

1.  Studies of a human lambda-chain epitope related to a complementarity-determining region.

Authors:  H S Kim; H F Deutsch
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

2.  Variable-region sequence homologies of human kappa-chains with idiotypic serologic similarities.

Authors:  H S Kim; H F Deutsch
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.